Abstract:Colorectal cancer (CRC) stands as a prevalent malignancy globally. A pivotal event in CRC pathogenesis involves the loss-of-function mutation in the APC gene, leading to the formation of benign polyps. Despite the well- established role of APC, , the contribution of CUL4B to CRC initiation in the pre-tumorous stage remains poorly understood. In this investigation, we generated a murine model by crossing Apc Min/ + mice with Cul4b Delta IEC Delta IEC mice to achieve specific deletion of Cul4b in the gut epithelium against an Apc Min/ + background. By employing histological methods, RNA-sequencing (RNA-seq), and flow cytometry, we assessed alterations and characterized the immune microenvironment. Our results unveiled that CUL4B deficiency in gut epithelium expedited Apc Min/ + adenoma formation. Notably, CUL4B in adenomas restrained the accumulation of tumor-infiltrating myeloid- derived suppressor cells (MDSCs). In vivo inhibition of MDSCs significantly delayed the growth of CUL4B deleted Apc Min/ + adenomas. Furthermore, the addition of MDSCs to in vitro cultured Apc Min/ + ; Cul4b Delta IEC Delta IEC adenoma organoids mitigated their alterations. Mechanistically, CUL4B directly interacted with the promoter of Csf3, , the gene encoding granulocyte-colony stimulating factor (G-CSF) by coordinating with PRC2. Inhibiting CUL4B epigenetically activated the expression of G-CSF, promoting the recruitment of MDSCs. These findings offer novel insights into the tumor suppressor-like roles of CUL4B in regulating Apc Min/ + adenomas, suggesting a potential therapeutic strategy for CRC initiation and progression in the context of activated Wnt signaling.

Enhanced Apc Min/ Plus Adenoma Formation after Epithelial CUL4B Deletion by Recruitment of Myeloid-Derived Suppressor Cells